EXPANSIÓN: Nanobots capta casi un millón de euros en una ronda semilla
La start-up catalana Nanobots Therapeutics, una spin-off del Instituto de Bioingeniería de Catalunya, ha captado 960.000 euros de capital privado.
Nanobots
Nanorobots capable of travelling through synovial fluid to fight arthritis
Samuel Sánchez, ICREA Research Professor at the Institute for Bioengineering of Catalonia (IBEC), will lead the OrthoBots project, which focuses on the treatment of joint diseases using nanorobots. To carry out the project, Sánchez has been awarded an ERC Proof of Concept Grant, a prestigious grant from the European Research Council.
IBEC celebrates 20th anniversary of nanorobot research
The Nanomotors International Conference was held in Barcelona from 2 to 5 June. The event, organised by the Institute of Bioengineering of Catalonia (IBEC) in collaboration with the ‘la Caixa’ Foundation, the Catalunya La Pedrera Foundation, and the European Research Council (ERC), brought together the most prominent international leaders in the field of nanomotors. For three days, they learned about the latest advances in biomedical applications and the collective behaviour of self-propelled nanomotors, from both experimental and theoretical perspectives.
Bladder tumours reduced by 90% using nanorobots
The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Led by the IBEC and CIC biomaGUNE, the study opens the door to new, more efficient treatments for bladder cancer.
Samuel Sanchez receives the Constantes y Vitales Award
IBEC researcher Samuel Sánchez has been honored with the 2023 Constantes y Vitales Award in the “Young Talent in Biomedical Research” category for his work on designing self-propelled nanorobots capable of delivering drugs within the human body. This initiative, presented by LaSexta and AXA Foundation, aims to foster biomedical research in Spain and spotlight the contributions of its scientists.
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000
The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in … Read more
Samuel Sánchez Receives ERC Proof of Concept Grant to Target Mucinous Tumors with his Nanorobots
Samuel Sánchez has successfully secured an “ERC Proof of Concept” grant, provided by the European Research Council (ERC), to explore the application of his nanorobots in the treatment of mucus-secreting tumors. This prestigious grant enables researchers to assess the feasibility and potential for knowledge transfer of their research projects.
Samuel Sánchez awarded the BASF-ICIQ Prize for Best Entrepreneur for his spin-off Nanobots Therapeutics
Today marked the second edition of the BASF-ICIQ Innovation and Entrepreneurship Awards, which reward excellence in the field of chemistry. The biomedical company Nanobots Therapeutics S.L., led by Prof. Samuel … Read more
Observed in vivo the collective movement of nanorobots
